Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Hematology reports

Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangoankar A, Kota VK.
PMID: 29071052
Hematol Rep. 2017 Sep 26;9(3):7083. doi: 10.4081/hr.2017.7083. eCollection 2017 Sep 26.

No abstract available.

Cite
Jillella AP, Arellano ML, Heffner LT, et al. Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2017;9(3):7083doi: 10.4081/hr.2017.7083.
Jillella, A. P., Arellano, M. L., Heffner, L. T., Gaddh, M., Langston, A. A., Khoury, H. J., Mangoankar, A., & Kota, V. K. (2017). Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports, 9(3), 7083. https://doi.org/10.4081/hr.2017.7083
Jillella, Anand P, et al. "Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation." Hematology reports vol. 9,3 (2017): 7083. doi: https://doi.org/10.4081/hr.2017.7083
Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangoankar A, Kota VK. Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2017 Sep 26;9(3):7083. doi: 10.4081/hr.2017.7083. eCollection 2017 Sep 26. PMID: 29071052; PMCID: PMC5641824.
Copy Download .nbib Format: NLM
Superovulation in the prepuberal calf.

Theriogenology

Jillella D, Baker AA.
PMID: 16725559
Theriogenology. 1981 Jan;15(1):120. doi: 10.1016/s0093-691x(81)80037-4.

No abstract available.

Cite
Jillella D, Baker AA. Superovulation in the prepuberal calf. Theriogenology. 1981;15(1):120doi: 10.1016/s0093-691x(81)80037-4.
Jillella, D., & Baker, A. A. (1981). Superovulation in the prepuberal calf. Theriogenology, 15(1), 120. https://doi.org/10.1016/s0093-691x(81)80037-4
Jillella, D, and Baker, A A. "Superovulation in the prepuberal calf." Theriogenology vol. 15,1 (1981): 120. doi: https://doi.org/10.1016/s0093-691x(81)80037-4
Jillella D, Baker AA. Superovulation in the prepuberal calf. Theriogenology. 1981 Jan;15(1):120. doi: 10.1016/s0093-691x(81)80037-4. PMID: 16725559.
Copy Download .nbib Format: NLM
Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study.

Cureus

Zafar A, Ikram A, Jillella DV, Kempuraj D, Khan MM, Bushnaq S, Adam H, Ortega-Gutierrez S, Quadri SA, Farooqui M, Zaheer A, Leira EC.
PMID: 29234571
Cureus. 2017 Oct 11;9(10):e1767. doi: 10.7759/cureus.1767.

Interleukin (IL)-37 is a new member of the IL-1 cytokine family with a defined role as a negative feedback inhibitor of proinflammatory responses. IL-37 has yet to be evaluated in non-immune-mediated neurological diseases, such as ischemic or hemorrhagic strokes....

Cite
Zafar A, Ikram A, Jillella DV, et al. Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study. Cureus. 2017;9(10):e1767doi: 10.7759/cureus.1767.
Zafar, A., Ikram, A., Jillella, D. V., Kempuraj, D., Khan, M. M., Bushnaq, S., Adam, H., Ortega-Gutierrez, S., Quadri, S. A., Farooqui, M., Zaheer, A., & Leira, E. C. (2017). Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study. Cureus, 9(10), e1767. https://doi.org/10.7759/cureus.1767
Zafar, Atif, et al. "Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study." Cureus vol. 9,10 (2017): e1767. doi: https://doi.org/10.7759/cureus.1767
Zafar A, Ikram A, Jillella DV, Kempuraj D, Khan MM, Bushnaq S, Adam H, Ortega-Gutierrez S, Quadri SA, Farooqui M, Zaheer A, Leira EC. Measurement of Elevated IL-37 Levels in Acute Ischemic Brain Injury: A Cross-sectional Pilot Study. Cureus. 2017 Oct 11;9(10):e1767. doi: 10.7759/cureus.1767. PMID: 29234571; PMCID: PMC5724808.
Copy Download .nbib Format: NLM
Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival.

Laboratory medicine

Singh G, Savage NM, Jillella AP, Bollag RJ.
PMID: 34388245
Lab Med. 2021 Aug 13; doi: 10.1093/labmed/lmab054. Epub 2021 Aug 13.

OBJECTIVE: Patients with light chain-predominant multiple myeloma have been shown to exhibit shorter survival. Retrospective comparison of clinical and laboratory data was undertaken to ascertain the likely cause(s) of this observation.METHODS: Records of patients with multiple myeloma seen at...

Cite
Singh G, Savage NM, Jillella AP, et al. Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival. Lab Med. 2021;doi: 10.1093/labmed/lmab054.
Singh, G., Savage, N. M., Jillella, A. P., & Bollag, R. J. (2021). Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival. Laboratory medicine, . https://doi.org/10.1093/labmed/lmab054
Singh, Gurmukh, et al. "Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival." Laboratory medicine vol. (2021). doi: https://doi.org/10.1093/labmed/lmab054
Singh G, Savage NM, Jillella AP, Bollag RJ. Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival. Lab Med. 2021 Aug 13; doi: 10.1093/labmed/lmab054. Epub 2021 Aug 13. PMID: 34388245.
Copy Download .nbib Format: NLM
A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.

British journal of haematology

Smith WR, McClish DK, Lottenberg R, Sisler IY, Sop D, Johnson S, Villella A, Liles D, Yang E, Chen I.
PMID: 34786695
Br J Haematol. 2022 Jan;196(1):193-203. doi: 10.1111/bjh.17952. Epub 2021 Nov 16.

Hydroxyurea (hydroxycarbamide) (HU) for sickle cell anaemia (SCA) is underutilised. Case management is an evidence-based health management strategy and in this regard patient navigators (PNs) may provide case management for SCA. We hypothesised that HU-eligible patients exposed to PNs...

Cite
Smith WR, McClish DK, Lottenberg R, et al. A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. Br J Haematol. 2021;196(1):193-203doi: 10.1111/bjh.17952.
Smith, W. R., McClish, D. K., Lottenberg, R., Sisler, I. Y., Sop, D., Johnson, S., Villella, A., Liles, D., Yang, E., & Chen, I. (2022). A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. British journal of haematology, 196(1), 193-203. https://doi.org/10.1111/bjh.17952
Smith, Wally R, et al. "A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence." British journal of haematology vol. 196,1 (2022): 193-203. doi: https://doi.org/10.1111/bjh.17952
Smith WR, McClish DK, Lottenberg R, Sisler IY, Sop D, Johnson S, Villella A, Liles D, Yang E, Chen I. A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. Br J Haematol. 2022 Jan;196(1):193-203. doi: 10.1111/bjh.17952. Epub 2021 Nov 16. PMID: 34786695.
Copy Download .nbib Format: NLM
ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Hematology reports

Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangaonkar A, Kota VK.
PMID: 31871613
Hematol Rep. 2019 Dec 04;11(4):8395. doi: 10.4081/hr.2019.8395. eCollection 2019 Nov 29.

No abstract available.

Cite
Jillella AP, Arellano ML, Heffner LT, et al. ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2019;11(4):8395doi: 10.4081/hr.2019.8395.
Jillella, A. P., Arellano, M. L., Heffner, L. T., Gaddh, M., Langston, A. A., Khoury, H. J., Mangaonkar, A., & Kota, V. K. (2019). ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematology reports, 11(4), 8395. https://doi.org/10.4081/hr.2019.8395
Jillella, Anand P, et al. "ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation." Hematology reports vol. 11,4 (2019): 8395. doi: https://doi.org/10.4081/hr.2019.8395
Jillella AP, Arellano ML, Heffner LT, Gaddh M, Langston AA, Khoury HJ, Mangaonkar A, Kota VK. ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation. Hematol Rep. 2019 Dec 04;11(4):8395. doi: 10.4081/hr.2019.8395. eCollection 2019 Nov 29. PMID: 31871613; PMCID: PMC6902306.
Copy Download .nbib Format: NLM
Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia.

The Journal of community and supportive oncology

Mangaonkar A, Xu H, Mohsin J, Mansour J, Chintalapally R, Keen R, Mondal AK, DeRemer D, Clemmons AB, Clark SM, Shah A, Jillela A, Kolhe R, Kota V.
PMID: 26955659
J Community Support Oncol. 2016 Feb;14(2):66-71. doi: 10.12788/jcso.0231.

BACKGROUND: Complete remission (CR) in acute myeloid leukemia (AML) is defined as having ≤5% leukemic blast cells in the bone marrow and return of normal hematopoiesis after the first induction cycle. There is a subset of patients, however, who...

Cite
Mangaonkar A, Xu H, Mohsin J, et al. Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia. J Community Support Oncol. 2016;14(2):66-71doi: 10.12788/jcso.0231.
Mangaonkar, A., Xu, H., Mohsin, J., Mansour, J., Chintalapally, R., Keen, R., Mondal, A. K., DeRemer, D., Clemmons, A. B., Clark, S. M., Shah, A., Jillela, A., Kolhe, R., & Kota, V. (2016). Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia. The Journal of community and supportive oncology, 14(2), 66-71. https://doi.org/10.12788/jcso.0231
Mangaonkar, Abhishek, et al. "Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia." The Journal of community and supportive oncology vol. 14,2 (2016): 66-71. doi: https://doi.org/10.12788/jcso.0231
Mangaonkar A, Xu H, Mohsin J, Mansour J, Chintalapally R, Keen R, Mondal AK, DeRemer D, Clemmons AB, Clark SM, Shah A, Jillela A, Kolhe R, Kota V. Prognostic value of complete remission with superior platelet counts in acute myeloid leukemia. J Community Support Oncol. 2016 Feb;14(2):66-71. doi: 10.12788/jcso.0231. PMID: 26955659.
Copy Download .nbib Format: NLM
Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USA.

Hematology reports

Bolds SL, Hassan SMK, Caprara CR, Debragga S, Simon KS, Karkhanis P, Gandhi A, Jillella AP, Kota V.
PMID: 31210917
Hematol Rep. 2019 May 23;11(2):7896. doi: 10.4081/hr.2019.7896. eCollection 2019 May 23.

Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia with high induction mortality in the general population despite evidence of high cure rates in the clinical trials. Aggressive supportive care is essential for ideal management of these...

Cite
Bolds SL, Hassan SMK, Caprara CR, et al. Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USA. Hematol Rep. 2019;11(2):7896doi: 10.4081/hr.2019.7896.
Bolds, S. L., Hassan, S. M. K., Caprara, C. R., Debragga, S., Simon, K. S., Karkhanis, P., Gandhi, A., Jillella, A. P., & Kota, V. (2019). Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USA. Hematology reports, 11(2), 7896. https://doi.org/10.4081/hr.2019.7896
Bolds, Sheldon L, et al. "Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USA." Hematology reports vol. 11,2 (2019): 7896. doi: https://doi.org/10.4081/hr.2019.7896
Bolds SL, Hassan SMK, Caprara CR, Debragga S, Simon KS, Karkhanis P, Gandhi A, Jillella AP, Kota V. Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USA. Hematol Rep. 2019 May 23;11(2):7896. doi: 10.4081/hr.2019.7896. eCollection 2019 May 23. PMID: 31210917; PMCID: PMC6547027.
Copy Download .nbib Format: NLM
Cardio-Cerebral Infarction, Free-Floating Thrombosis and Hyperperfusion in COVID-19.

Neurology international

Koneru S, Jillella DV, Nogueira RG.
PMID: 34208052
Neurol Int. 2021 Jun 11;13(2):266-268. doi: 10.3390/neurolint13020027.

Cardio-cerebral infarction, which refers to an acute ischemic stroke (AIS) and acute myocardial infarction (AMI) that occur concurrently, is an uncommon phenomenon with a grave prognosis. Intraluminal carotid thrombus (ICT) is an infrequently encountered cause of ischemic stroke and...

Cite
Koneru S, Jillella DV, Nogueira RG. Cardio-Cerebral Infarction, Free-Floating Thrombosis and Hyperperfusion in COVID-19. Neurol Int. 2021;13(2):266-268doi: 10.3390/neurolint13020027.
Koneru, S., Jillella, D. V., & Nogueira, R. G. (2021). Cardio-Cerebral Infarction, Free-Floating Thrombosis and Hyperperfusion in COVID-19. Neurology international, 13(2), 266-268. https://doi.org/10.3390/neurolint13020027
Koneru, Sitara, et al. "Cardio-Cerebral Infarction, Free-Floating Thrombosis and Hyperperfusion in COVID-19." Neurology international vol. 13,2 (2021): 266-268. doi: https://doi.org/10.3390/neurolint13020027
Koneru S, Jillella DV, Nogueira RG. Cardio-Cerebral Infarction, Free-Floating Thrombosis and Hyperperfusion in COVID-19. Neurol Int. 2021 Jun 11;13(2):266-268. doi: 10.3390/neurolint13020027. PMID: 34208052; PMCID: PMC8293395.
Copy Download .nbib Format: NLM
A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.

British journal of haematology

Smith WR, McClish DK, Lottenberg R, Sisler IY, Sop D, Johnson S, Villella A, Liles D, Yang E, Chen I.
PMID: 34786695
Br J Haematol. 2021 Nov 16; doi: 10.1111/bjh.17952. Epub 2021 Nov 16.

Hydroxyurea (hydroxycarbamide) (HU) for sickle cell anaemia (SCA) is underutilised. Case management is an evidence-based health management strategy and in this regard patient navigators (PNs) may provide case management for SCA. We hypothesised that HU-eligible patients exposed to PNs...

Cite
Smith WR, McClish DK, Lottenberg R, et al. A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. Br J Haematol. 2021;doi: 10.1111/bjh.17952.
Smith, W. R., McClish, D. K., Lottenberg, R., Sisler, I. Y., Sop, D., Johnson, S., Villella, A., Liles, D., Yang, E., & Chen, I. (2021). A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. British journal of haematology, . https://doi.org/10.1111/bjh.17952
Smith, Wally R, et al. "A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence." British journal of haematology vol. (2021). doi: https://doi.org/10.1111/bjh.17952
Smith WR, McClish DK, Lottenberg R, Sisler IY, Sop D, Johnson S, Villella A, Liles D, Yang E, Chen I. A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence. Br J Haematol. 2021 Nov 16; doi: 10.1111/bjh.17952. Epub 2021 Nov 16. PMID: 34786695.
Copy Download .nbib Format: NLM
Human Leukocyte Antigens class II (HLA II) gene profile from an admixed population of patients with type 1 diabetes with severe diabetic retinopathy: a nested case-control study in Brazil.

Diabetology & metabolic syndrome

Santos DC, Porto LC, Pizarro MH, de Melo LGN, Silva DA, Oliveira RV, Villela AP, Muniz LH, Soares C, Tannus LRM, Drummond KRG, Pinheiro AA, Mallmann F, Leal FSL, Malerbi FK, Morales PH, Gomes MB.
PMID: 34362434
Diabetol Metab Syndr. 2021 Aug 06;13(1):83. doi: 10.1186/s13098-021-00702-y.

BACKGROUND: Although the well-established role of the HLA genes on the predisposition of type 1 diabetes (T1D), its contribution to the development and progression of diabetic retinopathy is still unclear, especially in admixed populations. We aimed to study the...

Cite
Santos DC, Porto LC, Pizarro MH, et al. Human Leukocyte Antigens class II (HLA II) gene profile from an admixed population of patients with type 1 diabetes with severe diabetic retinopathy: a nested case-control study in Brazil. Diabetol Metab Syndr. 2021;13(1):83doi: 10.1186/s13098-021-00702-y.
Santos, D. C., Porto, L. C., Pizarro, M. H., de Melo, L. G. N., Silva, D. A., Oliveira, R. V., Villela, A. P., Muniz, L. H., Soares, C., Tannus, L. R. M., Drummond, K. R. G., Pinheiro, A. A., Mallmann, F., Leal, F. S. L., Malerbi, F. K., Morales, P. H., & Gomes, M. B. (2021). Human Leukocyte Antigens class II (HLA II) gene profile from an admixed population of patients with type 1 diabetes with severe diabetic retinopathy: a nested case-control study in Brazil. Diabetology & metabolic syndrome, 13(1), 83. https://doi.org/10.1186/s13098-021-00702-y
Santos, Deborah Conte, et al. "Human Leukocyte Antigens class II (HLA II) gene profile from an admixed population of patients with type 1 diabetes with severe diabetic retinopathy: a nested case-control study in Brazil." Diabetology & metabolic syndrome vol. 13,1 (2021): 83. doi: https://doi.org/10.1186/s13098-021-00702-y
Santos DC, Porto LC, Pizarro MH, de Melo LGN, Silva DA, Oliveira RV, Villela AP, Muniz LH, Soares C, Tannus LRM, Drummond KRG, Pinheiro AA, Mallmann F, Leal FSL, Malerbi FK, Morales PH, Gomes MB. Human Leukocyte Antigens class II (HLA II) gene profile from an admixed population of patients with type 1 diabetes with severe diabetic retinopathy: a nested case-control study in Brazil. Diabetol Metab Syndr. 2021 Aug 06;13(1):83. doi: 10.1186/s13098-021-00702-y. PMID: 34362434; PMCID: PMC8344141.
Copy Download .nbib Format: NLM
Stroke Following Acute Chest Syndrome in a Child With Sickle Cell Disease: A Possible Novel Mechanism.

Pediatric neurology

Kendel NE, Lo WD, Villella AD.
PMID: 34624608
Pediatr Neurol. 2021 Dec;125:32-33. doi: 10.1016/j.pediatrneurol.2021.09.007. Epub 2021 Sep 20.

No abstract available.

Cite
Kendel NE, Lo WD, Villella AD. Stroke Following Acute Chest Syndrome in a Child With Sickle Cell Disease: A Possible Novel Mechanism. Pediatr Neurol. 2021;125:32-33doi: 10.1016/j.pediatrneurol.2021.09.007.
Kendel, N. E., Lo, W. D., & Villella, A. D. (2021). Stroke Following Acute Chest Syndrome in a Child With Sickle Cell Disease: A Possible Novel Mechanism. Pediatric neurology, 12532-33. https://doi.org/10.1016/j.pediatrneurol.2021.09.007
Kendel, Nicole E, et al. "Stroke Following Acute Chest Syndrome in a Child With Sickle Cell Disease: A Possible Novel Mechanism." Pediatric neurology vol. 125 (2021): 32-33. doi: https://doi.org/10.1016/j.pediatrneurol.2021.09.007
Kendel NE, Lo WD, Villella AD. Stroke Following Acute Chest Syndrome in a Child With Sickle Cell Disease: A Possible Novel Mechanism. Pediatr Neurol. 2021 Dec;125:32-33. doi: 10.1016/j.pediatrneurol.2021.09.007. Epub 2021 Sep 20. PMID: 34624608.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries